These studies should pave the way towards the clinical development of small-molecule inhibitors against PI3K isoforms, in particular p110δ, which could alleviate harmful immune responses against self antigens, transplantation antigens and innocuous foreign antigens in allergy. Here, PIK3CD is linked to allergic disease.